| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 9.15 mm | 9.15 mm | 9.15 mm | 9.15 mm | 9.15 mm | 9.15 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 1.91 mm | 1.91 mm | 1.56 mm | 1.73 mm |
| Cash used (since last report) | n/a | n/a | 9.72 mm | 9.68 mm | 7.91 mm | 8.78 mm |
| Cash remaining | n/a | n/a | -564.76 k | -531.31 k | 1.25 mm | 366.42 k |
| Runway (months of cash) | n/a | n/a | -0.3 | -0.3 | 0.8 | 0.2 |
| 13F holders | Current |
|---|---|
| Total holders | 33 |
| Opened positions | 7 |
| Closed positions | 3 |
| Increased positions | 5 |
| Reduced positions | 3 |
| 13F shares | Current |
|---|---|
| Total value | 13.39 bn |
| Total shares | 36.41 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Sanderling Venture Partners VI | 24.82 mm | $0.00 |
| Flynn James E | 2.61 mm | $14.64 mm |
| BML Investment Partners | 1.24 mm | $921.00 k |
| Soleus Private Equity Fund III | 1.18 mm | $5.64 mm |
| Aisling Capital V | 1.04 mm | $5.84 mm |
| Deerfield Management | 1.00 mm | $4.43 bn |
| Valence Investments SPV VI | 860.98 k | $4.82 mm |
| Soleus Capital Management | 783.90 k | $3.47 bn |
| Soleus Capital Master Fund | 783.90 k | $4.00 mm |
| Leerink Revelation Healthcare Fund I | 542.03 k | $2.98 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Jan 25 | Alan Glicklich | Director Stock Option Common Stock | Grant | Acquire A | No | No | 3.02 | 20,000 | 60.40 k | 20,000 |
| 6 Dec 24 | Middleton Fred A | Common Stock | Buy | Acquire P | No | No | 2.65 | 4,800 | 12.72 k | 36,514 |
| 1 Nov 24 | Robert N Wilson | Common Stock | Buy | Acquire P | No | No | 3.75 | 53,333 | 200.00 k | 417,529 |
